CRVS Corvus Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$10,90
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$6,3952 haftanın en düşüğü
$26,9552 haftanın en yükseği
Piyasa Değeri (MRQ)
$917M
P/E
-20.6
Hisse Başına Kâr
$-0.53
rozetleriniz
52 Haftlık Aralık
$6–$27
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$33
P/E
-20.6
ROE
-21.6%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
CRVS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$10.90
Piyasa Değeri (MRQ)
$917M
P/E
-20.6
Hisse Başına Kâr
$-0.53
ROE
-21.6%
52 Haftlık Aralık
$6–$27
CRVS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-0.532019-12-31 → 2025-12-31
Serbest Nakit Akışı$-33M2018-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | CRVS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -20.65Y ort. ≈-5.2 | ≈-5.2 | · | · | |
| F/D (MRQ) | 4.15Y ort. ≈4.9 | ≈4.9 | 4.7 | Daha pahalı | |
| Fiyat / Serbest Nakit Akışı (TTM) | -20.35Y ort. ≈-6.4 | ≈-6.4 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -20.65Y ort. ≈-8.0 | ≈-8.0 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 13.35Y ort. ≈4.9 | ≈4.9 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | CRVS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -21.8%5Y ort. ≈-53.8% | ≈-53.8% | -51.0% | En üst düzey | |
| ROE | -21.6%5Y ort. ≈-95.0% | ≈-95.0% | -73.4% | En üst düzey | |
| ROIC | -70.2%5Y ort. ≈-62.6% | ≈-62.6% | -84.9% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | CRVS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 16.25Y ort. ≈4.6 | ≈4.6 | 13.8 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 0.55Y ort. ≈2.1 | ≈2.1 | 5.6 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
46.8%
Sonraki Rapor
Kas 02, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 11, 2026 | $-0.19 | $-0.16 | -17.4% |
| 31 Mart 2026 | May 6, 2026 | $-0.15 | $-0.15 | -3.0% |
| 31 Aralık 2025 | $-0.15 | $-0.13 | -13.7% | |
| 30 Eylül 2025 | $-0.12 | $-0.14 | 11.8% | |
| 30 Haziran 2025 | $-0.10 | $-0.14 | 29.9% | |
| 31 Mart 2025 | $0.21 | $-0.12 | 273.3% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $34M | $19M | $17M | $24M | $29M | $32M | $38M | $39M | $46M | $29M | $11M | |
| SG&A Expense | $9M | $8M | $7M | $8M | $10M | $12M | $11M | $11M | $10M | $8M | $2M | |
| Operating Expenses | $43M | $28M | $23M | $33M | $39M | $44M | $49M | $49M | $57M | $37M | $14M | |
| Operating Income | $-43M | $-28M | $-23M | $-33M | $-39M | $-44M | $-49M | $-49M | $-57M | $-37M | $-14M | |
| Pretax Income | $-13M | $-59M | $-22M | $-31M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | $-31M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-15M | $-62M | $-27M | $-41M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | $-31M | |
| EPS (Basic) | $-0.19 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | · | · | · | · | |
| EPS (Diluted) | $-0.53 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | · | · | · | · | |
| Shares (Basic) | 78,964,842 | 60,985,165 | 48,025,274 | 46,553,511 | 41,854,110 | 29,478,878 | 29,349,810 | · | · | · | · | |
| Shares (Diluted) | 79,742,685 | 60,985,165 | 48,025,274 | 46,553,511 | 41,854,110 | 29,478,878 | 29,349,810 | · | · | · | · | |
| EBITDA | $-43M | $-27M | $-23M | $-32M | $-38M | $-43M | $-48M | $-48M | · | · | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $9M | $13M | $13M | $63M | $16M | $5M | $39M | $45M | $5M | $4M | |
| Receivables | $37.0K | $75.0K | $26.0K | $588.0K | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $2M | $781.0K | $773.0K | $1M | $1M | $1M | $992.0K | $1M | $1M | $1M | |
| Other Current Assets | $353.0K | $548.0K | $220.0K | $102.0K | $128.0K | $406.0K | $486.0K | $265.0K | $412.0K | $772.0K | $208.0K | |
| Current Assets | $58M | $54M | $28M | $44M | $71M | $45M | $79M | $116M | $91M | $136M | $96M | |
| PP&E (Net) | $220.0K | $151.0K | $236.0K | $353.0K | $451.0K | $906.0K | $1M | $2M | $3M | $3M | $2M | |
| PP&E (Gross) | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $2M | |
| Accum. Depreciation | $3M | $5M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $729.0K | $135.0K | |
| Other Non-current Assets | $855.0K | $632.0K | $89.0K | $129.0K | $236.0K | $414.0K | $513.0K | $463.0K | $869.0K | $869.0K | · | |
| Total Assets | $71M | $69M | $46M | $68M | $109M | $86M | $84M | $118M | $95M | $140M | $98M | |
| Accounts Payable | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | |
| Accrued Liabilities | $6M | $4M | $4M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $9M | $35M | $7M | $11M | $10M | $12M | $10M | $7M | $9M | $6M | $3M | |
| Capital Leases | $534.0K | $937.0K | · | $1M | $3M | $1M | $2M | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $869.0K | $971.0K | $1M | $710.0K | |
| Total Liabilities | $10M | $36M | $7M | $12M | $12M | $13M | $13M | $8M | $10M | $7M | $4M | |
| Common Stock | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | · | |
| Paid-in Capital | $474M | $431M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-412M | $-397M | $-335M | $-308M | $-266M | $-223M | $-217M | $-170M | $-124M | $-68M | $-31M | |
| AOCI | $-896.0K | $-1M | $-967.0K | $-563.0K | $2M | $4.0K | $29.0K | $-34.0K | $-41.0K | $-39.0K | $-45.0K | |
| Stockholders' Equity | $61M | $33M | $39M | $56M | $97M | $72M | $71M | $110M | $85M | $133M | $-31M | |
| Liabilities + Equity | $71M | $69M | $46M | $68M | $109M | $86M | $84M | $118M | $95M | $140M | $98M | |
| Shares Outstanding | 74,696,629 | 67,899,779 | 49,038,582 | 46,553,511 | 46,553,511 | 28,372,634 | 27,953,233 | 29,323,930 | 21,041,250 | 20,922,428 | 1,431,615 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $105.0K | $85.0K | $151.0K | $367.0K | $460.0K | $632.0K | $743.0K | $847.0K | $842.0K | $594.0K | $148.0K | |
| Stock-based Comp | $5M | $3M | $2M | $3M | $4M | $6M | $7M | $7M | $6M | $4M | $428.0K | |
| Other Non-cash | $-23M | $34M | $796.0K | $11M | $2M | $-35M | $1M | $-2M | · | · | · | |
| Operating Cash Flow | $-33M | $-25M | $-24M | $-27M | $-37M | $-35M | $-37M | $-41M | $-46M | $-28M | $-11M | |
| CapEx | $174.0K | · | $34.0K | $269.0K | $5.0K | $76.0K | $25.0K | $355.0K | $266.0K | $2M | $2M | |
| Investing Cash Flow | $-8M | $-27M | $16M | $-23M | $22M | $45M | $3M | $-30M | $85M | $-43M | $-92M | |
| Stock Issued | · | $16M | · | · | $32M | · | · | $65M | $711.0K | $71M | · | |
| Net Stock Activity | · | $16M | · | · | $32M | · | · | $65M | · | · | · | |
| Financing Cash Flow | $36M | $49M | $8M | $0 | $62M | $1M | $24.0K | $65M | $1M | $71M | $95M | |
| Net Change in Cash | $-4M | $-4M | $-539.0K | $-50M | $47M | $11M | $-34M | $-6M | $40M | $945.0K | $-8M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-33M | · | $-24M | $-27M | $-37M | $-35M | $-37M | $-41M | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -21.8% | -108.9% | -47.5% | -46.5% | -44.4% | -7.1% | -46.2% | -44.1% | · | · | · | |
| ROE | -21.6% | -277.0% | -65.1% | -68.4% | -42.8% | -10.5% | -61.6% | -41.0% | · | · | · | |
| ROIC | -70.2% | -84.6% | -60.5% | -58.0% | -39.8% | -60.7% | -68.7% | -44.6% | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.2 | 1.5 | 4.1 | 4.1 | 7.4 | 3.7 | 7.8 | 16.4 | · | · | · | |
| Quick Ratio | 0.5 | 0.2 | 1.8 | 1.2 | 6.5 | 1.4 | 0.5 | 5.6 | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.82 | $0.48 | $0.79 | $1.21 | $2.09 | $2.54 | $2.54 | $3.76 | · | · | · | |
| Cash Flow / Share | $-0.41 | $-0.42 | $-0.50 | $-0.58 | $-0.88 | · | · | · | · | · | · | |
| Cash / Share | $0.06 | $0.13 | $0.26 | $0.28 | $1.36 | $0.58 | $0.18 | $1.34 | · | · | · | |
| EPS (TTM) | $-0.53 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-15M | $-62M | $-27M | $-41M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | · | |
| Market Cap | $575M | $363M | $86M | $40M | $112M | $101M | $152M | $108M | · | · | · | |
| P/E | -14.5 | -5.2 | -3.1 | -1.0 | -2.3 | -17.8 | -3.4 | · | · | · | · | |
| P/B | 9.4 | 11.2 | 2.2 | 0.7 | 1.2 | 1.4 | 2.1 | 1.0 | · | · | · | |
| P / Tangible Book | 9.4 | 11.2 | 2.2 | 0.7 | 1.2 | 1.4 | · | · | · | · | · | |
| P / Cash Flow | -17.5 | -14.3 | -3.6 | -1.5 | -3.1 | -2.9 | -4.1 | -2.6 | · | · | · | |
| P / FCF | -17.4 | · | -3.6 | -1.4 | -3.1 | -2.9 | -4.1 | -2.6 | · | · | · | |
| Earnings Yield | -6.9% | -19.1% | -31.8% | -104.7% | -42.7% | -5.6% | -29.2% | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $16M | $11M | $10M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $4M | $4M | $5M | $10M | $5M | $5M | |
| SG&A Expense | $3M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $19M | $15M | $12M | $11M | $10M | $10M | $8M | $7M | $6M | $6M | $6M | $6M | $7M | $12M | $7M | $7M | |
| Operating Income | $-19M | $-15M | $-12M | $-11M | $-10M | $-10M | $-8M | $-7M | $-6M | $-6M | $-6M | $-6M | $-7M | $-12M | $-7M | $-7M | |
| Other Non-op | · | $1M | · | $415.0K | $2M | $25M | · | $-33M | $2M | $-552.0K | · | · | · | · | · | · | |
| Pretax Income | $-17M | $-13M | $-12M | $-10M | $-8M | $16M | $-10M | $-40M | $-4M | $-6M | $-5M | $-5M | $-6M | · | · | · | |
| Income Tax | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-18M | $-14M | $-12M | $-10M | $-8M | $15M | $-12M | $-40M | $-4M | $-6M | $-6M | $-7M | $-8M | $-15M | $-8M | $-8M | |
| EPS (Basic) | $-0.19 | $-0.15 | $-0.18 | $-0.12 | $-0.10 | $0.21 | $-0.23 | $-0.60 | $-0.07 | $-0.12 | $-0.12 | $-0.14 | $-0.17 | $-0.32 | $-0.18 | $-0.18 | |
| EPS (Diluted) | $-0.19 | $-0.15 | $-0.18 | $-0.12 | $-0.10 | $-0.13 | $-0.23 | $-0.60 | $-0.07 | $-0.12 | $-0.12 | $-0.14 | $-0.17 | $-0.32 | $-0.18 | $-0.18 | |
| Shares (Basic) | 92,368,013 | 89,996,728 | · | 82,836,369 | 77,774,344 | 72,126,496 | · | 66,701,086 | 59,710,265 | 49,038,582 | 48,971,246 | 47,497,414 | 46,556,178 | 46,553,511 | 46,553,511 | 46,553,511 | |
| Shares (Diluted) | 92,368,013 | 89,996,728 | · | 82,836,369 | 77,774,344 | 75,152,514 | · | 66,701,086 | 59,710,265 | 49,038,582 | 48,971,246 | 47,497,414 | 46,556,178 | 46,553,511 | 46,553,511 | 46,553,511 | |
| EBITDA | $-19M | $-15M | · | $-11M | $-10M | $-10M | · | $-7M | $-6M | $-6M | $-6M | $-6M | $-7M | $-12M | $-7M | $-7M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $40M | $5M | $3M | $15M | $5M | $9M | $5M | $15M | $7M | $20M | $8M | $10M | $25M | $28M | $31M | |
| Receivables | $6.0K | $43.0K | $37.0K | $32.0K | $86.0K | $79.0K | $75.0K | $70.0K | $35.0K | $26.0K | $11.0K | · | · | · | · | · | |
| Prepaid Expense | $6M | $3M | $1M | $1M | $1M | $1M | $2M | $1M | $977.0K | $697.0K | $915.0K | $893.0K | $655.0K | $1M | $2M | $1M | |
| Other Current Assets | $575.0K | $367.0K | $318.0K | $509.0K | $569.0K | $458.0K | $548.0K | $633.0K | $240.0K | $267.0K | $214.0K | $136.0K | $131.0K | $397.0K | $395.0K | $130.0K | |
| Current Assets | $221M | $240M | $58M | $67M | $76M | $45M | $54M | $43M | $48M | $23M | $33M | $38M | $36M | $51M | $59M | $64M | |
| PP&E (Net) | $830.0K | $282.0K | $220.0K | $221.0K | $249.0K | $165.0K | $151.0K | $171.0K | $192.0K | $213.0K | $264.0K | $294.0K | $330.0K | $447.0K | $527.0K | $364.0K | |
| PP&E (Gross) | $4M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | |
| Other Non-current Assets | $2M | $2M | $855.0K | $852.0K | $626.0K | $629.0K | $632.0K | $252.0K | $129.0K | $89.0K | $89.0K | $129.0K | $129.0K | $248.0K | $236.0K | $236.0K | |
| Total Assets | $239M | $253M | $71M | $80M | $89M | $59M | $69M | $59M | $65M | $40M | $52M | $58M | $58M | $80M | $93M | $101M | |
| Accounts Payable | $4M | $5M | $2M | $2M | $3M | $1M | $3M | $2M | $1M | $2M | $1M | $2M | $1M | $4M | $3M | $2M | |
| Accrued Liabilities | $9M | $7M | $6M | $6M | $5M | $4M | $4M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $14M | $12M | $9M | $8M | $9M | $9M | $35M | $46M | $13M | $7M | $7M | $8M | $8M | $14M | $10M | $9M | |
| Capital Leases | $274.0K | $406.0K | $534.0K | $632.0K | $728.0K | $834.0K | $937.0K | · | · | · | $354.0K | $700.0K | $1M | $2M | $2M | $2M | |
| Total Liabilities | $14M | $13M | $10M | $9M | $9M | $10M | $36M | $46M | $13M | $7M | $8M | $9M | $9M | $16M | $12M | $12M | |
| Common Stock | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $671M | $668M | $474M | · | · | · | $431M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-444M | $-426M | $-412M | $-400M | $-390M | $-382M | $-397M | $-385M | $-345M | $-340M | $-328M | $-322M | $-316M | $-298M | $-283M | $-275M | |
| AOCI | $-1M | $-1M | $-896.0K | $-1M | $-1M | $-1M | $-1M | $-738.0K | $-1M | $-1M | $-1M | $-1M | $-434.0K | $-1M | $339.0K | $2M | |
| Stockholders' Equity | $225M | $241M | $61M | $72M | $80M | $49M | $33M | $12M | $51M | $33M | $44M | $49M | $49M | $65M | $80M | $90M | |
| Liabilities + Equity | $239M | $253M | $71M | $80M | $89M | $59M | $69M | $59M | $65M | $40M | $52M | $58M | $58M | $80M | $93M | $101M | |
| Shares Outstanding | 84,120,944 | 84,090,424 | 74,696,629 | 74,681,872 | 74,514,039 | 68,169,461 | 67,899,779 | 62,580,031 | 62,551,281 | 49,038,582 | 49,038,582 | 48,898,362 | 46,568,511 | 46,553,511 | 46,553,511 | 46,553,511 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34.0K | $29.0K | $26.0K | $28.0K | $29.0K | $22.0K | $20.0K | $21.0K | $21.0K | $23.0K | $30.0K | $36.0K | $57.0K | $94.0K | $92.0K | $87.0K | |
| Stock-based Comp | $3M | $3M | $2M | $1M | $1M | $1M | $813.0K | $733.0K | $768.0K | $689.0K | $546.0K | $537.0K | $492.0K | $658.0K | $675.0K | $739.0K | |
| Other Non-cash | · | $639.0K | · | · | · | $-25M | · | · | · | $-168.0K | · | · | $-787.0K | · | · | $1M | |
| Operating Cash Flow | $-15M | $-10M | $-9M | $-10M | $-6M | $-8M | $-8M | $-6M | $-5M | $-5M | $-5M | $-5M | $-8M | $-7M | $-6M | $-6M | |
| CapEx | $582.0K | $91.0K | $25.0K | $0 | $113.0K | $36.0K | · | · | · | · | $0 | $0 | $34.0K | $265.0K | · | · | |
| Investing Cash Flow | $-6M | $-145M | $11M | $-3M | $-20M | $4M | $-6M | $-4M | $-18M | $-7.0K | $18M | $-4M | $5M | $3M | $3M | $-26M | |
| Stock Issued | $0 | $189M | · | · | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $189M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $166.0K | $191M | $20.0K | $360.0K | $36M | $279.0K | $19M | $50.0K | · | · | $335.0K | $8M | $4.0K | · | · | · | |
| Net Change in Cash | $-21M | $36M | $2M | $-12M | $10M | $-4M | $4M | $-10M | $7M | $-5M | $12M | $-2M | $-4M | $-4M | $-3M | $-32M | |
| Free Cash Flow | · | $-10M | · | · | · | $-8M | · | · | · | · | · | · | $-8M | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.9% | -8.8% | · | -14.6% | -10.4% | 30.5% | · | -72.6% | -7.0% | -11.6% | -9.1% | -8.6% | -9.9% | -14.9% | -8.3% | -7.9% | |
| ROE | -11.8% | -9.4% | · | -24.1% | -12.2% | 36.8% | · | -141.9% | -8.5% | -13.9% | -11.0% | -10.0% | -11.4% | -17.5% | -9.5% | -9.0% | |
| ROIC | · | -6.2% | · | · | · | · | · | · | · | -18.7% | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.2 | 19.8 | · | 8.3 | 8.9 | 4.9 | · | 0.9 | 3.6 | 3.4 | 4.5 | 4.8 | 4.3 | 3.7 | 5.8 | 6.9 | |
| Quick Ratio | 1.4 | 3.3 | · | 0.4 | 1.7 | 0.5 | · | 0.1 | 1.1 | 1.1 | 2.8 | 1.0 | 1.2 | 1.8 | 2.8 | 3.4 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.68 | $2.86 | · | $0.96 | $1.08 | $0.72 | · | $0.20 | $0.82 | $0.68 | $0.90 | $1.01 | $1.05 | $1.39 | $1.73 | $1.93 | |
| Cash Flow / Share | · | $-0.12 | · | · | · | $-0.11 | · | · | · | $-0.11 | · | · | $-0.17 | · | · | $-0.14 | |
| Cash / Share | $0.22 | $0.48 | · | $0.04 | $0.20 | $0.07 | · | $0.07 | $0.24 | $0.15 | $0.41 | $0.16 | $0.21 | $0.53 | $0.61 | $0.68 | |
| EPS (TTM) | $-0.64 | $-0.55 | · | $-0.58 | $-1.06 | $-1.03 | · | $-0.92 | $-0.44 | $-0.51 | $-0.64 | $-0.84 | $-0.88 | $-0.85 | $-0.77 | $-0.87 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-54M | $-44M | · | $-15M | $-45M | $-41M | · | $-57M | $-23M | $-25M | $-30M | $-39M | $-41M | $-41M | $-37M | $-40M | |
| Market Cap | $1.26B | $1.23B | · | $550M | $298M | $217M | · | $330M | $114M | $87M | $72M | $112M | $42M | $38M | $46M | $76M | |
| P/E | -23.3 | -26.6 | · | -12.7 | -3.8 | -3.1 | · | -5.7 | -4.1 | -3.5 | -2.3 | -2.7 | -1.0 | -1.0 | -1.3 | -1.9 | |
| P/B | 5.6 | 5.1 | · | 7.7 | 3.7 | 4.4 | · | 26.6 | 2.2 | 2.6 | 1.6 | 2.3 | 0.9 | 0.6 | 0.6 | 0.9 | |
| P / Tangible Book | 5.6 | 5.1 | · | 7.7 | 3.7 | 4.4 | · | 26.6 | 2.2 | 2.6 | 1.6 | 2.3 | 0.9 | 0.6 | 0.6 | 0.9 | |
| P / Cash Flow | · | -118.6 | · | · | · | -26.2 | · | · | · | -16.9 | · | · | -5.2 | · | · | -11.9 | |
| Earnings Yield | -4.3% | -3.8% | · | -7.9% | -26.5% | -32.4% | · | -17.4% | -24.2% | -28.6% | -43.8% | -36.7% | -96.7% | -103.8% | -77.8% | -53.0% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Gelir | $-15M | $-62M | $-27M | $-41M | $-43M |
| Seyreltilmiş Hisse Başı Kâr | $-0.53 | $-1.02 | $-0.56 | $-0.89 | $-1.03 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 6.2 | 1.5 | 4.1 | 4.1 | 7.4 |
| Cari Oran | 0.5 | 0.2 | 1.8 | 1.2 | 6.5 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-33M | · | $-24M | $-27M | $-37M |
Kurumsal Sahipler (13F) 187 dosya · $1.1B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
187
Tutulan Değer
$1.1B
Yeni pozisyonlar
41
Çıkan pozisyonlar
28
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 41 (-28 önceki Ç'ye göre) | 28 (+7 önceki Ç'ye göre) | 72 (+12 önceki Ç'ye göre) | 43 (+14 önceki Ç'ye göre) | +1.0M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | $107.045.190 | 7.165.006 | 10,14% | Hisse senetleri |
| BlackRock, Inc. | $106.653.837 | 7.138.811 | 10,10% | Hisse senetleri |
| STATE STREET CORP | $66.842.920 | 4.474.091 | 6,33% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $49.193.087 | 3.292.710 | 4,66% | Hisse senetleri |
| ADAMS STREET PARTNERS LLC | $48.937.703 | 3.275.616 | 4,63% | Hisse senetleri |
| Vivo Capital, LLC | $41.918.891 | 2.805.816 | 3,97% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $40.810.581 | 2.731.632 | 3,87% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $39.851.569 | 2.667.441 | 3,77% | Hisse senetleri |
| Deep Track Capital, LP | $37.229.569 | 2.491.939 | 3,53% | Hisse senetleri |
| BRAIDWELL LP | $31.766.892 | 2.126.298 | 3,01% | Hisse senetleri |
| VANGUARD GROUP INC | $29.825.811 | 3.873.482 | 2,82% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $27.700.900 | 1.853.659 | 2,62% | Hisse senetleri |
| Foresite Capital Management VI LLC | $27.358.621 | 1.831.233 | 2,59% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $23.550.700 | 1.576.352 | 2,23% | Hisse senetleri |
| Hood River Capital Management LLC | $23.482.767 | 1.571.805 | 2,22% | Hisse senetleri |
| MORGAN STANLEY | $20.090.356 | 1.344.736 | 1,90% | Hisse senetleri |
| Boxer Capital Management, LLC | $16.434.000 | 1.100.000 | 1,56% | Hisse senetleri |
| Catalio Capital Management, LP | $16.148.467 | 1.080.888 | 1,53% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $15.656.896 | 1.047.985 | 1,48% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.172.365 | 814.750 | 1,15% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $11.731.008 | 785.208 | 1,11% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $11.321.503 | 757.798 | 1,07% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $11.205.000 | 750.000 | 1,06% | Hisse senetleri |
| Eversept Partners, LP | $11.175.030 | 747.994 | 1,06% | Hisse senetleri |
| EMERALD ADVISERS, LLC | $10.244.104 | 685.683 | 0,97% | Hisse senetleri |
| DCF Advisers, LLC | $9.524.250 | 637.500 | 0,90% | Hisse senetleri |
| Blue Owl Capital Holdings LP | $9.092.484 | 608.600 | 0,86% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8.739.900 | 585.000 | 0,83% | Alım opsiyonu |
| NORTHERN TRUST CORP | $8.592.861 | 575.158 | 0,81% | Hisse senetleri |
| EMERALD MUTUAL FUND ADVISERS TRUST | $7.864.252 | 526.389 | 0,74% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $7.776.688 | 520.528 | 0,74% | Hisse senetleri |
| RA CAPITAL MANAGEMENT, L.P. | $6.723.000 | 450.000 | 0,64% | Hisse senetleri |
| Nextech Invest Ltd. | $6.723.000 | 450.000 | 0,64% | Hisse senetleri |
| CITADEL ADVISORS LLC | $6.675.192 | 446.800 | 0,63% | Alım opsiyonu |
| CITADEL ADVISORS LLC | $5.945.388 | 397.951 | 0,56% | Hisse senetleri |
| UBS Group AG | $5.917.973 | 396.116 | 0,56% | Hisse senetleri |
| BARCLAYS PLC | $4.717.289 | 315.749 | 0,45% | Hisse senetleri |
| Jump Financial, LLC | $4.682.196 | 313.400 | 0,44% | Hisse senetleri |
| Trexquant Investment LP | $4.427.424 | 296.347 | 0,42% | Hisse senetleri |
| DIADEMA PARTNERS LP | $4.404.476 | 294.811 | 0,42% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.101.030 | 274.500 | 0,39% | Satım opsiyonu |
| Polymer Capital Management (HK) LTD | $3.939.110 | 263.662 | 0,37% | Hisse senetleri |
| Brevan Howard Capital Management LP | $3.739.348 | 250.291 | 0,35% | Hisse senetleri |
| SPHERA FUNDS MANAGEMENT LTD. | $3.659.717 | 244.961 | 0,35% | Hisse senetleri |
| Spruce Street Capital LP | $3.459.880 | 231.585 | 0,33% | Hisse senetleri |
| SEB Asset Management AB | $3.388.938 | 226.837 | 0,32% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $3.298.169 | 220.761 | 0,31% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $3.253.185 | 217.750 | 0,31% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.109.298 | 208.119 | 0,29% | Hisse senetleri |
| Bank of New York Mellon Corp | $3.026.973 | 202.609 | 0,29% | Hisse senetleri |
Aktivistler ve %5+ sahipler 5 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Adams Street Partners, LLC, Adams Street 2011 Direct Fund LP, Adams Street 2012 Direct Fund LP, Adams Street 2013 Direct Fund LP, Adams Street 2014 Direct Fund LP, Adams Street 2015 Direct Venture/Growth Fund LP, Adams Street 2016 Direct Venture/Growth Fund LP, Adams Street 2017 Direct Venture/Growth Fund LP, Adams Street 2018 Direct Venture/Growth Fund LP, Adams Street Venture/Growth Fund VI LP ×2 başvurular | 05 Şubat 2026 | 3,90% | Değişiklik | · | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×13 başvurular | 27 Ocak 2026 | 10,30% | Değişiklik | · | SEC |
| Novo Holdings A/S ×2 başvurular | 09 Temmuz 2020 | · | İlk başvuru | · | SEC |
| Novo Holdings A/S (formerly known as Novo A/S) | 31 Ocak 2019 | · | İlk başvuru | · | SEC |
| Novo A/S | 30 Mart 2016 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 23 içeriden öğrenenler · 9 yöneticiler · 12 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Richard A Miller MD | President and CEO | 18 Mayıs 2026 P | 1.195.035 | 2 | 0 | $83.453 |
| Leiv Lea | Chief Financial Officer | 04 Aralık 2025 A | 133.238 | 0 | 0 | $0 |
| Jeffrey Arcara | Chief Business Officer | 04 Aralık 2025 A | · | 0 | 0 | $0 |
| William Benton Jones | SVP, Pharmaceutical Development | 04 Aralık 2025 A | 173.130 | 0 | 0 | $0 |
| Mehrdad Mobasher | SVP, Chief Medical Officer | 16 Aralık 2020 A | · | 0 | 0 | $0 |
| Daniel W. Hunt | SVP, Chief Business Officer | 12 Aralık 2019 A | · | 0 | 0 | $0 |
| Erik J. Verner | VP, Chemistry Research | 12 Aralık 2019 A | · | 0 | 0 | $0 |
| Joseph J Buggy | EVP, Discovery Research | 12 Aralık 2019 A | · | 0 | 0 | $0 |
| Jason V Coloma | SVP, Chief Business Officer | 08 Haziran 2016 A | · | 0 | 0 | $0 |
| David Scott Moore | Yönetim kurulu üyesi | 11 Haziran 2026 A | 21.700 | 1 | 0 | $250.201 |
| Richard Van Den Broek | Yönetim kurulu üyesi | 11 Haziran 2026 A | · | 0 | 0 | $0 |
| Linda S Grais | Yönetim kurulu üyesi | 11 Haziran 2026 A | 10.000 | 0 | 0 | $0 |
| Peter A. Thompson | Yönetim kurulu üyesi | 11 Haziran 2026 A | 210.000 | 0 | 0 | $0 |
| Ian T Clark | Yönetim kurulu üyesi | 11 Haziran 2026 A | · | 0 | 0 | $0 |
| Andrew C. Chan | Yönetim kurulu üyesi | 23 Nisan 2026 A | · | 0 | 0 | $0 |
| Scott W Morrison | Yönetim kurulu üyesi | 12 Haziran 2025 A | · | 0 | 0 | $0 |
| Terry P Gould | Yönetim kurulu üyesi | 13 Haziran 2024 A | 126.806 | 0 | 0 | $0 |
| Edith P. Mitchell | Yönetim kurulu üyesi | 06 Aralık 2023 A | · | 0 | 0 | $0 |
| Steve E. Krognes | Yönetim kurulu üyesi | 09 Haziran 2020 A | · | 0 | 0 | $0 |
| ORBIMED ADVISORS LLC | Yönetim kurulu üyesi | 29 Mart 2016 C | 5.258.450 | 0 | 0 | $0 |
| Adams Street Partners, LLC | 10% sahip | 11 Ağustos 2022 A | 126.806 | 0 | 0 | $0 |
| EcoR1 Capital, LLC | 10% sahip | 01 Ekim 2021 S | 81.077 | 0 | 0 | $0 |
| Novo Holdings A/S | 10% sahip | 08 Temmuz 2020 S | 1.389.498 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 28 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IDNA · iShares Trust | 0,79% | 156.836 SH | 11 Eylül 2026 | Günlük |
| BBC · ETFis Series Trust I | 0,74% | 26.054 NS | 31 Temmuz 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,27% | 99.617 NS | 31 Temmuz 2026 | N-PORT |
| IWC · iShares Trust | 0,21% | 230.273 SH | 11 Eylül 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,12% | 156.977 SH | 19 Ağustos 2026 | Günlük |
| PWS · Pacer Funds Trust | 0,08% | 1.361 NS | 31 Temmuz 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,06% | 6.010 SH | 02 Ekim 2026 | Günlük |
| IBB · iShares Trust | 0,06% | 481.850 SH | 11 Eylül 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 72.574 SH | 19 Ağustos 2026 | Günlük |
| IWO · iShares Trust | 0,06% | 635.860 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 390.005 SH | 19 Ağustos 2026 | Günlük |
| PKW · Invesco Exchange-Traded Fund Trust | 0,03% | 45.560 SH | 02 Ekim 2026 | Günlük |
| IWM · iShares Trust | 0,03% | 1.739.484 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,03% | 32.355 NS | 31 Temmuz 2026 | N-PORT |
| TECB · iShares Trust | 0,02% | 6.211 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 29.935 NS | 31 Temmuz 2026 | N-PORT |
| ISCG · iShares Trust | 0,01% | 7.679 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 844.478 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,01% | 189.601 SH | 19 Ağustos 2026 | Günlük |
| WSML · iShares Trust | 0,01% | 4.491 SH | 11 Eylül 2026 | Günlük |
| TILT · FlexShares Trust | 0,00% | 4.266 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 108.998 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 22.681 SH | 10 Eylül 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.374.106 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.593 SH | 19 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | · | 2.886 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 8.903 SH | 11 Eylül 2026 | Günlük |
| SMLF · iShares Trust | · | 36.191 SH | 11 Eylül 2026 | Günlük |
CRVS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 14 analist
AL
Medyan hedef
$32.00
+193,6%
5 35,7%
Güçlü Al
8 57,1%
Al
1 7,1%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
7 analist · 2026-10-04Ortalama hedef $33.14 +204,1%
← Tüm hedeflerin altında
Mevcut fiyat $10.90
Düşük$27.00
Ortalama$33.14
Yüksek$42.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CRVS | $575M | -14.5 | · | · | -21.6% | · |
| CGEM | $624M | -3.2 | · | · | -44.0% | · |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
| SANA | $1.09B | -4.2 | · | · | -172.3% | · |
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
| OBX | · | · | · | · | · | · |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026